Standout Papers

AMSTAR 2: a critical apprai... 1995 2026 2005 2015 6.2k
  1. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017)
    Beverley Shea, Barnaby C Reeves et al. BMJ
  2. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007)
    Beverley Shea, Jeremy Grimshaw et al. BMC Medical Research Methodology
  3. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? (1998)
    David Moher, Ba’ Pham et al. The Lancet
  4. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis (1995)
    David T. Felson, Jennifer J. Anderson et al. Arthritis & Rheumatism
  5. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee (2012)
    Marc C. Hochberg, Roy D. Altman et al. Arthritis Care & Research
  6. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology (2010)
    Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology
  7. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines (2008)
    Weiya Zhang, Roland W. Moskowitz et al. Osteoarthritis and Cartilage
  8. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)
    A. Laupacis, David Feeny et al. PubMed
  9. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials (1993)
    David T. Felson, Jennifer J. Anderson et al. Arthritis & Rheumatism
  10. OARSI recommendations for the management of hip and knee osteoarthritis (2010)
    Weiya Zhang, G. Nuki et al. Osteoarthritis and Cartilage
  11. Developing core outcome sets for clinical trials: issues to consider (2012)
    Paula Williamson, Douglas G. Altman et al. Trials
  12. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists (1995)
    David Moher, Alejandro R. Jadad et al. Controlled Clinical Trials
  13. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health (2013)
    Jennifer O’Neill, Vivian Welch et al. Journal of Clinical Epidemiology
  14. A simplified disease activity index for rheumatoid arthritis for use in clinical practice (2003)
    Josef S Smolen, FC Breedveld et al. Lara D. Veeken
  15. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline (2016)
    C.A.C. Prinsen, Sunita Vohra et al. Trials
  16. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. (1997)
    Nicholas Bellamy, John Kirwan et al. PubMed
  17. Measuring disease-specific quality of life in clinical trials. (1986)
    Gordon Guyatt, Claire Bombardier et al. PubMed Central
  18. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? (2000)
    Laura McAuley, Ba’ Pham et al. The Lancet
  19. What types of interventions generate inequalities? Evidence from systematic reviews (2012)
    Theo Lorenc, Mark Petticrew et al. Journal of Epidemiology & Community Health
  20. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence (2007)
    Weiya Zhang, Roland W. Moskowitz et al. Osteoarthritis and Cartilage
  21. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. (1990)
    Marcos Bosi Ferraz, Marina Rodrigues Quaresma et al. PubMed
  22. Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 (2014)
    Maarten Boers, John Kirwan et al. Journal of Clinical Epidemiology
  23. The effect of elective total hip replacement on health-related quality of life. (1993)
    Andreas Laupacis, Robert B. Bourne et al. Journal of Bone and Joint Surgery
  24. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation (1998)
    Annette M. O’Connor, Peter Tugwell et al. Patient Education and Counseling
  25. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity (2012)
    Vivian Welch, Mark Petticrew et al. PLoS Medicine
  26. Guideline for opioid therapy and chronic noncancer pain (2017)
    Jason W. Busse, Samantha Craigie et al. Canadian Medical Association Journal
  27. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis (2015)
    Jasvinder A. Singh, Chris Cameron et al. The Lancet
  28. Core Outcome Set–STAndards for Reporting: The COS-STAR Statement (2016)
    Jamie J Kirkham, Sarah L. Gorst et al. PLoS Medicine
  29. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review (2018)
    Alessandro Chiarotto, Lara Maxwell et al. Journal of Pain
  30. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis (2021)
    Bruno R. da Costa, Tiago Pereira et al. BMJ

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 216 standout
Sub-graph 1 of 17

Citing Papers

Applied body-fluid analysis by wearable devices
2024 StandoutNature
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
2022 Standout

Works of Peter Tugwell being referenced

Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
2015 Standout
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
2003 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Peter Tugwell 18386 9992 6864 12763 789 71.3k
George A. Wells 10998 5797 3478 17537 864 86.7k
Claire Bombardier 11381 4975 3241 13978 344 53.4k
Jan P. Vandenbroucke 6952 9765 5045 21047 439 107.2k
Julian P. T. Higgins 7336 8389 5810 31545 446 178.4k
Rachelle Buchbinder 7577 6486 2876 13802 603 44.3k
Peter W.F. Wilson 8559 3031 7091 30320 632 107.0k
Joost Dekker 7989 3902 1753 9678 887 51.6k
Cathy D. Sherbourne 4813 15585 6241 11249 223 79.2k
Holger J. Schünemann 3608 9844 8513 14708 693 82.6k
Mike Clarke 3656 12057 6735 21439 582 119.1k

All Works

Loading papers...

Rankless by CCL
2026